Britain’s drug regulator accepted the Alzheimer’s drug Kisunla on Wednesday, but the government received’t be purchasing it right after an independent watchdog company explained the therapy isn’t definitely worth the Charge to taxpayersFifty several years in the past, Philadelphia prison officials ended a medical tests program that experien